Prelude Therapeutics Inc (PRLD)

12:53 PM

What drives Prelude Therapeutics Incorporated stock priceUnmatched profit growth - PrintWeekIndia

12:53 PM

12:43 PM

Is Prelude Therapeutics Incorporated a good long term investmentSkyrocketing investment returns - PrintWeekIndia

12:43 PM

09:31 AM

What analysts say about Prelude Therapeutics Incorporated stockRapid wealth accumulation - Autocar Professional

09:31 AM

02:31 AM

Will Prelude Therapeutics Incorporated stock split in the near futureExplosive trading opportunities - jammulinksnews.com

02:31 AM

Jul 24, 2025

Prelude Therapeutics Advances Cancer Treatment with PRT7732 Study - TipRanks

Jul 24, 2025

Jul 22, 2025

Prelude Therapeutics Incorporated Stock Analysis and ForecastExplosive capital gains - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

what makes prelude therapeutics incorporated stock price move sharplyFree Investment Community - Newser

Jul 19, 2025

Jul 18, 2025

Is Prelude Therapeutics Incorporated stock a good hedge against inflation10x Return With Managed Risk - Newser

Jul 18, 2025

Jul 15, 2025

What makes Prelude Therapeutics Incorporated stock price move sharplyFree Access to Investment Community - Newser

Jul 15, 2025

Jul 15, 2025

Why Prelude Therapeutics Incorporated stock attracts strong analyst attentionPro Trader Stock Focus - Newser

Jul 15, 2025

Jul 15, 2025

How Prelude Therapeutics Incorporated stock performs during market volatilityFree Smart Investment Opportunities - Newser

Jul 15, 2025

Jul 11, 2025

Prelude Therapeutics’ PRT7732 Study: A Potential Game-Changer for SMARCA4 Mutations - TipRanks

Jul 11, 2025

Jun 27, 2025

Prelude Therapeutics Advances PRT3789 in Phase 1 Study for SMARCA4 Mutant Tumors - TipRanks

Jun 27, 2025

Jun 26, 2025

Prelude Therapeutics Advances Cancer Treatment with New Phase 2 Study - TipRanks

Jun 26, 2025

Jun 23, 2025

Transcript : Prelude Therapeutics Incorporated Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 09 - MarketScreener

Jun 23, 2025

Jun 17, 2025

Baker Bros. Advisors LP Increases Stake in Prelude Therapeutics Inc. - GuruFocus

Jun 17, 2025

Jun 11, 2025

Two Sigma Investments LP Purchases 174,906 Shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD) - Defense World

Jun 11, 2025

Jun 08, 2025

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Shares Acquired by Millennium Management LLC - Defense World

Jun 08, 2025

Jun 06, 2025

20,572 Shares in Prelude Therapeutics Incorporated (NASDAQ:PRLD) Purchased by BNP Paribas Financial Markets - Defense World

Jun 06, 2025

Jun 06, 2025

Two Sigma Advisers LP Raises Holdings in Prelude Therapeutics Incorporated (NASDAQ:PRLD) - Defense World

Jun 06, 2025

Jun 06, 2025

Phio Pharmaceuticals Advances 30-Drug Cancer Portfolio as Phase 1b Trial Shows Promise - Stock Titan

Jun 06, 2025

Jun 04, 2025

Prelude Therapeutics describes new SMARCA2 and SMARCA4 degradation inducers - BioWorld MedTech

Jun 04, 2025

Jun 04, 2025

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Shares Sold by Northern Trust Corp - Defense World

Jun 04, 2025

Jun 02, 2025

Prelude Therapeutics to Present at Major Healthcare Conferences in June 2025 - MyChesCo

Jun 02, 2025

Jun 02, 2025

Prelude Therapeutics to Participate in Upcoming Healthcare Confe - GuruFocus

Jun 02, 2025

Jun 02, 2025

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences | PRLD Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

Precision Oncology Pioneer Prelude Therapeutics Sets Stage for Major June Healthcare Conference Updates - Stock Titan

Jun 02, 2025